Trials / Withdrawn
WithdrawnNCT01956513
Contribution of MRI in the Evaluation of Apparent Diffusion Coefficient and Prediction of Response to Neoadjuvant Chemotherapy in Breast Cancer
Etude ADC Apport de l'IRM Dans l'évaluation du Coefficient de Diffusion Apparent et prédiction de la réponse à la chimiothérapie néoadjuvante Dans le Cancer du Sein
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Centre Jean Perrin · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The main objective of the study is to assess the sensitivity and the specificity of the variation of apparent diffusion coefficient for prediction, after a course of neoadjuvant chemotherapy or after modification of the treatment sequence, the pathological response at the end of chemotherapy
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | MRI (Magnetic resonance imaging) | MRI will be realised at the beginning of the study, after a cycle of chemotherapy or at changement of sequence and at the end of chemotherapy. |
Timeline
- Start date
- 2012-03-01
- Primary completion
- 2013-10-01
- Completion
- 2013-10-01
- First posted
- 2013-10-08
- Last updated
- 2013-10-08
Source: ClinicalTrials.gov record NCT01956513. Inclusion in this directory is not an endorsement.